These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24002087)

  • 1. A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation.
    Martin PM; Yang X; Robin N; Lam E; Rabinowitz JS; Erdman CA; Quinn J; Weiss LA; Hamilton SP; Kwok PY; Moon RT; Cheyette BN
    Transl Psychiatry; 2013 Sep; 3(9):e301. PubMed ID: 24002087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling.
    Mäkitie RE; Hackl M; Niinimäki R; Kakko S; Grillari J; Mäkitie O
    J Clin Endocrinol Metab; 2018 May; 103(5):1985-1996. PubMed ID: 29506076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of WNT1 mutant variant (WNT1
    Zhang B; Li R; Wang W; Zhou X; Luo B; Zhu Z; Zhang X; Ding A
    Ann Hum Genet; 2020 Nov; 84(6):447-455. PubMed ID: 32757296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
    Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
    Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction.
    Sowers LP; Loo L; Wu Y; Campbell E; Ulrich JD; Wu S; Paemka L; Wassink T; Meyer K; Bing X; El-Shanti H; Usachev YM; Ueno N; Manak JR; Shepherd AJ; Ferguson PJ; Darbro BW; Richerson GB; Mohapatra DP; Wemmie JA; Bassuk AG
    Mol Psychiatry; 2013 Oct; 18(10):1077-89. PubMed ID: 23711981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Mäkitie RE; Niinimäki R; Kakko S; Honkanen T; Kovanen PE; Mäkitie O
    Osteoporos Int; 2018 Feb; 29(2):479-487. PubMed ID: 29147753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective WNT signaling may protect from articular cartilage deterioration - a quantitative MRI study on subjects with a heterozygous WNT1 mutation.
    Lehtovirta S; Mäkitie RE; Casula V; Haapea M; Niinimäki J; Niinimäki T; Peuna A; Lammentausta E; Mäkitie O; Nieminen MT
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1636-1646. PubMed ID: 31299386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability.
    Torrico B; Fernàndez-Castillo N; Hervás A; Milà M; Salgado M; Rueda I; Buitelaar JK; Rommelse N; Oerlemans AM; Bralten J; Freitag CM; Reif A; Battaglia A; Mazzone L; Maestrini E; Cormand B; Toma C
    Eur J Hum Genet; 2015 Dec; 23(12):1694-701. PubMed ID: 25782667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder.
    Uddin M; Tammimies K; Pellecchia G; Alipanahi B; Hu P; Wang Z; Pinto D; Lau L; Nalpathamkalam T; Marshall CR; Blencowe BJ; Frey BJ; Merico D; Yuen RK; Scherer SW
    Nat Genet; 2014 Jul; 46(7):742-7. PubMed ID: 24859339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.
    Xing J; Wang C; Kimura H; Takasaki Y; Kunimoto S; Yoshimi A; Nakamura Y; Koide T; Banno M; Kushima I; Uno Y; Okada T; Aleksic B; Ikeda M; Iwata N; Ozaki N
    PLoS One; 2014; 9(11):e112531. PubMed ID: 25393624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls.
    Munesue T; Yokoyama S; Nakamura K; Anitha A; Yamada K; Hayashi K; Asaka T; Liu HX; Jin D; Koizumi K; Islam MS; Huang JJ; Ma WJ; Kim UH; Kim SJ; Park K; Kim D; Kikuchi M; Ono Y; Nakatani H; Suda S; Miyachi T; Hirai H; Salmina A; Pichugina YA; Soumarokov AA; Takei N; Mori N; Tsujii M; Sugiyama T; Yagi K; Yamagishi M; Sasaki T; Yamasue H; Kato N; Hashimoto R; Taniike M; Hayashi Y; Hamada J; Suzuki S; Ooi A; Noda M; Kamiyama Y; Kido MA; Lopatina O; Hashii M; Amina S; Malavasi F; Huang EJ; Zhang J; Shimizu N; Yoshikawa T; Matsushima A; Minabe Y; Higashida H
    Neurosci Res; 2010 Jun; 67(2):181-91. PubMed ID: 20435366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients.
    Alanazi MS; Parine NR; Shaik JP; Alabdulkarim HA; Ajaj SA; Khan Z
    PLoS One; 2013; 8(3):e59555. PubMed ID: 23516639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression.
    Chen B; Zhao Y; Han D; Zhao B; Mao Y; Cui ZK; Chu YC; Feng L; Yin S; Wang CY; Wang X; Xu MJ; Zhao G
    J Mol Cell Cardiol; 2019 Oct; 135():10-21. PubMed ID: 31356809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.
    Yadav A; Gupta A; Yadav S; Rastogi N; Agrawal S; Kumar A; Kumar V; Misra S; Mittal B
    Tumour Biol; 2016 Jun; 37(6):8083-95. PubMed ID: 26715268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for interaction between markers in GABA(A) receptor subunit genes in an Argentinean autism spectrum disorder population.
    Sesarini CV; Costa L; Naymark M; Grañana N; Cajal AR; García Coto M; Pallia RC; Argibay PF
    Autism Res; 2014 Feb; 7(1):162-6. PubMed ID: 24249596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways.
    Wexler EM; Rosen E; Lu D; Osborn GE; Martin E; Raybould H; Geschwind DH
    Sci Signal; 2011 Oct; 4(193):ra65. PubMed ID: 21971039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.